The National Academies Press

Currently Skimming:

Strategies for Building Confidence in the COVID-19 Vaccines
Pages 1-21

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.

From page 1... ... SEAN links researchers in the social, behavioral, and economic sciences with decision makers to respond to policy questions arising from the COVID-19 pandemic. This project is affiliated with the National Academies' Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats, sponsored by the U.S. Read the entire page →
From page 2... ... Moreover, it will be essential to provide people who are hesitant, reluctant, distrusting, or otherwise unmotivated with respect to the COVID-19 vaccines with the resources, information, and support they need to make the vaccination decision that is right for them. This rapid expert consultation highlights overall strategies for engaging the public and building community trust (Box 1) Read the entire page →
From page 3... ... This rapid expert consultation provides guidance on meeting the second challenge. It is intended to assist decision makers in building public confidence in the COVID-19 vaccines and in communicating with the public about the vaccination process and rollout by highlighting strategies for public engagement and message delivery to ensure demand and promote acceptance. Read the entire page →
From page 4... ... Dedicating more resources and technical assistance to local efforts in conjunction with national campaigns could support rapid learning and ultimately increase vaccine acceptance at the community level. UNDERSTANDING COVID-19 VACCINE HESITANCY The public's opinions on vaccination fall along a continuum, ranging from those who fully accept vaccines, to those who are vaccine hesitant (two groups that collectively represent the majority of the population) Read the entire page →
From page 5... ... The phased rollout of available COVID-19 vaccines, all authorized under the EUA mechanism, may provide an opportunity for responding to hesitancy in this respect: officials can make safety and effectiveness data transparent and accessible, especially as additional vaccines are authorized. Acknowledging people's uncertainty and their desire for more data becomes possible as vaccination programs continue. Read the entire page →
From page 6... ... Public engagement is more likely to be impactful (and build trust beyond COVID-19 vaccination programs) if the process is established and designed so that public values (ascertained through engagement) Read the entire page →
From page 7... ... 2. Engage with and Center the Voices and Perspectives of Trusted Messengers Who Have Roots in the Community Evidence suggests that efforts to counter vaccine hesitancy and promote vaccination need to emphasize putting "people at the center" of those efforts (Schoch-Spana et al., 2020) Read the entire page →
From page 8... ... The group works across nine counties and has recently focused its efforts on COVID-19 response while continuing to highlight the importance of broader social determinants of health in shaping community health outcomes, particularly among communities of color (Bay Area Regional Health Inequities Initiative, 2020; Kritz, 2020) Read the entire page →
From page 9... ... EFFECTIVE COMMUNICATION TO BUILD CONFIDENCE IN THE COVID-19 VACCINES Principles for Effective Communication This section highlights five principles of effective risk communication, adapted from guidance issued by the CDC: (1) do not wait; (2) Read the entire page →
From page 10... ... Communication Strategies for Promoting Acceptance of the COVID-19 Vaccines There is no single solution to vaccine hesitancy. Rather, multiple nuanced approaches are key to ensuring that those who are hesitant do not evolve to outright vaccine refusal and that existing health inequities are addressed. Read the entire page →
From page 11... ... Occasionally, however, public health practitioners may have to address false claims (Ecker et al., 2017) Read the entire page →
From page 12... ... Ultimately, communication themes being emphasized today may be inappropriate or incomplete in several months as circumstances change, and campaigns will be forced to adapt accordingly. Recognition of the dynamism of COVID-19 vaccine hesitancy is key to the construction of effective communication strategies, which must mirror the dynamism of beliefs. Read the entire page →
From page 13... ... Anthony Fauci on his video series and national vaccine experts participating in local town hall meetings. Likewise, in Baltimore, public health experts and researchers have partnered with faith leaders in the Black community to reach out to and educate community members about both COVID-19 and influenza (Sokolow, 2020) Read the entire page →
From page 14... ... SEAN is interested in your feedback. Was this rapid expert consultation useful? Read the entire page →
From page 15... ... Duke Global Health Institute Commentary. https://globalhealth.duke.edu/news/duke-experts-meet-vaccine-skeptics-empathy information (accessed January 19, 2021) Read the entire page →
From page 16... ... 2020. "Trusted messengers, trusted messages": How to overcome vaccine hesitancy. Read the entire page →
From page 17... ... Baltimore, MD: Johns Hopkins Bloomberg School of Public Health Center for Health Security. Read the entire page →
From page 18... ... Atlanta, GA: CDC. https://www.cdc.gov/eis/field-epi-manual/chapters/Communicating-Investigation.html (accessed January 19, 2021) Read the entire page →
From page 19... ... We thank as well the Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats, particularly Harvey Fineberg (Gordon and Betty Moore Foundation) Read the entire page →
From page 20... ... , Georgetown University DOMINIQUE BROSSARD, University of Wisconsin-Madison JANET CURRIE, Princeton, University MICHAEL HOUT, New York University ARATI PRABHAKAR, Actuate ADRIAN E RAFTERY, University of Washington JENNIFER RICHESON, Yale University Staff MONICA N Read the entire page →
From page 21... ... DUCHIN, University of Washington ELLEN EMBREY, Stratitia, Inc BARUCH FISCHHOFF, Carnegie Mellon University DIANE GRIFFIN, Johns Hopkins Bloomberg School of Public Health ROBERT GROVES, Georgetown University MARGARET HAMBURG, Foreign Associate, National Academy of Medicine DAN HANFLING, In-Q-Tel JOHN HICK, Hennepin County Medical Center KENT E KESTER, Sanofi Pasteur PATRICIA KING, Georgetown University Law Center JONNA MAZET, University of California, Davis School of Veterinary Medicine PHYLLIS MEADOWS, The Kresge Foundation TARA O'TOOLE, In-Q-Tel ALEXANDRA PHELAN, Georgetown University DAVID RELMAN, Stanford University MARK SMOLINSKI, Ending Pandemics DAVID WALT, Harvard Medical School Project Staff LISA BROWN, Senior Program Officer AUTUMN DOWNEY, Senior Program Officer CAROLYN SHORE, Senior Program Officer SCOTT WOLLEK, Senior Program Officer AURELIA ATTAL-JUNCQUA, Associate Program Officer EMMA FINE, Associate Program Officer BENJAMIN KAHN, Associate Program Officer MICHAEL BERRIOS, Research Associate BRIDGET BOREL, Administrative Assistant JULIE PAVLIN, Director, Board on Global Health ANDREW M Read the entire page →

From page 1...

... SEAN links researchers in the social, behavioral, and economic sciences with decision makers to respond to policy questions arising from the COVID-19 pandemic. This project is affiliated with the National Academies' Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats, sponsored by the U.S.

Strategies for Building Confidence in the COVID-19 Vaccines Pages 1-21

Strategies for Building Confidence in the COVID-19 Vaccines
Pages 1-21